ANXA5, annexin A5, 308

N. diseases: 283; N. variants: 10
Disease: Glioma ×
Source: ALL
Variant Gene Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs1131239
rs1131239
Entrez Id: 308
Gene Symbol: ANXA5
ANXA5
CUI: C0017638
Disease:
Glioma 		0.010 GeneticVariation BEFREE Haplotype analysis showed that haplotype ″GACCG″ in the block (rs41278075, rs2306420, rs117677079, rs2306415 and rs1131239) significantly decreased the susceptibility of glioma (OR 0.61, p = 0.003). 30536196 2019
dbSNP: rs117677079
rs117677079
Entrez Id: 308
Gene Symbol: ANXA5
ANXA5
CUI: C0017638
Disease:
Glioma 		0.010 GeneticVariation BEFREE Haplotype analysis showed that haplotype ″GACCG″ in the block (rs41278075, rs2306420, rs117677079</span>, rs2306415 and rs1131239) significantly decreased the susceptibility of glioma (OR 0.61, p = 0.003). 30536196 2019
dbSNP: rs145619195
rs145619195
Entrez Id: 308
Gene Symbol: ANXA5
ANXA5
CUI: C0017638
Disease:
Glioma 		0.010 GeneticVariation BEFREE Whereas, rs145619195 CT genotype might weaken the susceptibility (OR 0.63, p = 0.024) and prognosis (HR 0.20, p = 0.025) of glioma. 30536196 2019
dbSNP: rs2306415
rs2306415
Entrez Id: 308
Gene Symbol: ANXA5
ANXA5
CUI: C0017638
Disease:
Glioma 		0.010 GeneticVariation BEFREE Haplotype analysis showed that haplotype ″GACCG″ in the block (rs41278075, rs2306420, rs117677079, rs2306415 and rs1131239) significantly decreased the susceptibility of glioma (OR 0.61, p = 0.003). 30536196 2019
dbSNP: rs2306420
rs2306420
Entrez Id: 308
Gene Symbol: ANXA5
ANXA5
CUI: C0017638
Disease:
Glioma 		0.010 GeneticVariation BEFREE Haplotype analysis showed that haplotype ″GACCG″ in the block (rs41278075, rs2306420, rs117677079, rs2306415 and rs1131239) significantly decreased the susceptibility of glioma (OR 0.61, p = 0.003). 30536196 2019
dbSNP: rs41278075
rs41278075
Entrez Id: 308
Gene Symbol: ANXA5
ANXA5
CUI: C0017638
Disease:
Glioma 		0.010 GeneticVariation BEFREE Haplotype analysis showed that haplotype ″GACCG″ in the block (rs41278075, rs2306420, rs117677079, rs2306415 and rs1131239) significantly decreased the susceptibility of glioma (OR 0.61, p = 0.003). 30536196 2019